AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 47 filers reported holding AUTOLUS THERAPEUTICS PLC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $191,783 | +15.0% | 82,310 | +17.4% | 0.00% | – |
| Q2 2023 | $166,821 | +40.9% | 70,093 | +8.9% | 0.00% | – |
| Q1 2023 | $118,436 | +266.7% | 64,367 | +278.7% | 0.00% | – |
| Q4 2022 | $32,299 | -63.7% | 16,999 | -59.3% | 0.00% | – |
| Q3 2022 | $89,000 | -24.6% | 41,775 | -0.7% | 0.00% | – |
| Q2 2022 | $118,000 | -61.7% | 42,073 | -43.0% | 0.00% | – |
| Q1 2022 | $308,000 | +555.3% | 73,858 | +716.1% | 0.00% | – |
| Q4 2021 | $47,000 | -4.1% | 9,050 | +20.7% | 0.00% | – |
| Q3 2021 | $49,000 | -54.2% | 7,495 | -53.4% | 0.00% | – |
| Q2 2021 | $107,000 | 0.0% | 16,081 | -14.1% | 0.00% | – |
| Q1 2021 | $107,000 | +114.0% | 18,714 | +237.6% | 0.00% | – |
| Q4 2020 | $50,000 | +31.6% | 5,544 | +70.1% | 0.00% | – |
| Q3 2020 | $38,000 | -51.9% | 3,259 | -33.5% | 0.00% | – |
| Q2 2020 | $79,000 | +315.8% | 4,898 | +51.5% | 0.00% | – |
| Q1 2020 | $19,000 | -55.8% | 3,233 | 0.0% | 0.00% | – |
| Q4 2019 | $43,000 | +7.5% | 3,233 | -0.1% | 0.00% | – |
| Q3 2019 | $40,000 | -23.1% | 3,235 | -0.1% | 0.00% | – |
| Q2 2019 | $52,000 | +79.3% | 3,238 | +266.3% | 0.00% | – |
| Q4 2018 | $29,000 | +1350.0% | 884 | +1063.2% | 0.00% | – |
| Q3 2018 | $2,000 | -75.0% | 76 | -74.0% | 0.00% | – |
| Q2 2018 | $8,000 | – | 292 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 21,346,829 | $49,738,112 | 74.10% |
| TFG Asset Management GP Ltd | 12,000,000 | $27,960,000 | 5.10% |
| Paradigm Biocapital Advisors LP | 14,406,782 | $33,567,802 | 2.28% |
| Lynx1 Capital Management LP | 1,363,025 | $3,175,848 | 2.10% |
| Deep Track Capital, LP | 15,000,000 | $34,950,000 | 1.35% |
| Affinity Asset Advisors, LLC | 1,992,466 | $4,642,446 | 1.31% |
| DAFNA Capital Management LLC | 928,253 | $2,162,829 | 0.67% |
| Frazier Life Sciences Management, L.P. | 3,746,857 | $8,730,177 | 0.58% |
| ARMISTICE CAPITAL, LLC | 6,900,000 | $16,077,000 | 0.25% |
| Blackstone Inc. | 20,485,611 | $47,731,474 | 0.20% |